David Shulman, MD
Dr. David Shulman studies novel therapies and biomarkers for advanced pediatric solid tumors within the Dana-Farber Experimental Therapeutics Program. In addition to early phase clinical trials, Dr. Shulman also studies...
Dr. David Shulman studies novel therapies and biomarkers for advanced pediatric solid tumors within the Dana-Farber Experimental Therapeutics Program. In addition to early phase clinical trials, Dr. Shulman also studies...
Jennifer Snaman is PACT Attending and an Attending in Neuro-oncology at Boston Children’s Hospital. She completed fellowships in Pediatric Hematology/Oncology and Hospice and Palliative Medicine at St. Jude Children’s Research...
This research study is a Three arm Phase I clinical trial, which tests the safety of an investigational drug or combination of drugs and also tries to define the appropriate dose of the combination of ...
Dr. Yeo earned his medical degree at Jefferson Medical College of Thomas Jefferson University in 2011. After internship and residency training at Children's National Medical Center, he completed a pediatric...